Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies (NCT06254742) | Jiangsu HengRui Medicine Co., Ltd. | 2024-02-01 |
Track Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk automatically
Every clearance here is in the API, with alerts when new ones post.